Breaking News Instant updates and real-time market news.

APHA

Aphria

$5.39

1.06 (24.48%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47

Aphria rises 21.8%

Aphria is up 21.8%, or 95c to $5.31.

  • 15

    Oct

  • 12

    Nov

APHA Aphria
$5.39

1.06 (24.48%)

10/09/19
ROTH
10/09/19
NO CHANGE
ROTH
Roth says low enthusiasm for cannabis stocks doesn't reflect industry potential
Roth Capital analyst Scott Fortune noted that stocks in the cannabis sector have declined during the six months since the first quarter with the industry "mired in a capital crunch, with a vape crisis to make matters worse." However, he thinks the recently lower enthusiasm for cannabis stocks does not reflect the cannabis industry's prospects, as he still sees a lot of upside potential. A "meaningful shift" in investor focus to operational execution has led to a short-term correction in valuations, but the industry is still projected to grow at a 27% compound annual growth rate for the next three years, said Fortune, who advises that investors focus for now on companies with strong balance sheets and positive adjusted EBITDA who are nearing break even. Publicly traded companies in the cannabis space include Aphria (APHA), Aurora Cannabis (ACB), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), Tilray (TLRY), and Trulieve Cannabis (TCNNF).
10/10/19
STFL
10/10/19
NO CHANGE
STFL
Hexo miss further damages cannabis industry credibility, says Stifel
Hexo (HEXO) this morning provided a preliminary update for its fiscal Q4 with revenue coming in below the consensus estimate and well below the "double" offered by management mid-quarter during the Q3 earnings call, Stifel analyst Andrew Carter tells investors in a research note. The preannouncement is "another headline damaging" the cannabis industry's credibility, Carter tells investors in a research note. For companies facing "significant financing risk," the analyst believes a "real segregation of assets will occur." Some companies will face significant dilution due to onerous financing terms while others will simply be unable to access capital, predicts the analyst. Carter thinks the macro environment will continue to be difficult and that the capital positions of Canopy Growth (CGC) and Cronos Group (CRON) are "clear competitive advantages." Those two have the ability to continue executing their business plans while capitalizing on the sector weakness, which "will only intensify from here," says Carter. Other names in the cannabis space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), General Cannabis (CANN), India Globalization Capital (IGC), Tilray (TLRY) and Zynerba (ZYNE). Shares of Hexo are down 24%, or 90c, to $2.78 in early trading.
10/11/19
JEFF
10/11/19
UPGRADE
JEFF
Hold
Jefferies upgrades Hexo to Hold, says pressures now understood
Jefferies analyst Owen Bennett upgraded Hexo (HEXO) to Hold from Underperform with a price target of $2.90. The pressures facing the company are now better understood following its weaker than expected outlook, Bennett tells investors in a research note. The analyst this morning also downgraded Canopy Growth (CGC) to Underperform from Hold. His top picks Cannabis are Aurora Cannabis (ACB), Aphria (APHA) and Green Organic Dutchman (TGODF).
10/14/19
GHSC
10/14/19
DOWNGRADE
GHSC
Neutral
Canopy, Hexo downgraded to Neutral as Seaport Global cuts cannabis estimates
Seaport Global analyst Brett Hundley lowered his sales and earnings forecasts for the conventional Canadian cannabis companies he covers as part of a broader reset of expectations for the Canadian cannabis space. As part of the broader changes, he downgraded Canopy Growth (CGC) and Hexo Corp. (HEXO), both to Neutral from Buy. Hundley has lowered his FY21 view for Canopy's revenue to $475.5M and his EBITDA forecast to ($75.1M), adding that he no longer feels confident in the company's potential to receive incremental equity warrant funding from Constellation (STZ) in the near-term. For Hexo, he now sees FY21 revenue of $121.7M and $0.2M in EBITDA. He expects market pricing to become "considerably more challenged" as industry production funnels into "a limited store set" in Canada, Hundley tells investors. He keeps a Buy rating on Aphria (APHA), making it his only Buy-rated conventional Canadian cannabis company, though he cut his price target on the stock to $8 from $13. Hundley has Neutral ratings on Aurora Cannabis (ACB) and Tilray (TLRY).

TODAY'S FREE FLY STORIES

ORAN

Orange SA

$15.98

0.06 (0.38%)

05:58
11/15/19
11/15
05:58
11/15/19
05:58
Periodicals
Orange SA preparing to split mobile towers into separate company, FT reports »

Orange is preparing to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$38.52

1.89 (5.16%)

05:57
11/15/19
11/15
05:57
11/15/19
05:57
Upgrade
Barclays double upgrades GrubHub, says stock worth well over $50 in buyout »

Barclays analyst Deepak…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPOR

Gulfport Energy

$3.10

-0.1 (-3.13%)

05:57
11/15/19
11/15
05:57
11/15/19
05:57
Downgrade
Gulfport Energy rating change  »

Gulfport Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$120.65

-0.41 (-0.34%)

05:49
11/15/19
11/15
05:49
11/15/19
05:49
Recommendations
Walmart analyst commentary  »

Nomura Instinet lists…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$56.89

-0.24 (-0.42%)

05:45
11/15/19
11/15
05:45
11/15/19
05:45
Upgrade
Applied Materials rating change  »

Applied Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

  • 09

    Dec

JD

JD.com

$33.57

0.21 (0.63%)

05:38
11/15/19
11/15
05:38
11/15/19
05:38
Earnings
Breaking Earnings news story on JD.com »

JD.com sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 09

    Dec

JD

JD.com

$33.57

0.21 (0.63%)

05:37
11/15/19
11/15
05:37
11/15/19
05:37
Earnings
JD.com reports Q3 EPS 29c, consensus 17c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 09

    Dec

NVDA

Nvidia

$209.88

1.33 (0.64%)

05:34
11/15/19
11/15
05:34
11/15/19
05:34
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 06

    Jan

AMAT

Applied Materials

$56.89

-0.24 (-0.42%)

05:31
11/15/19
11/15
05:31
11/15/19
05:31
Recommendations
Applied Materials analyst commentary  »

Applied Materials price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

  • 09

    Dec

MAT

Mattel

$12.32

0.35 (2.92%)

05:30
11/15/19
11/15
05:30
11/15/19
05:30
Conference/Events
Mattel to host business news update conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

MITK

Mitek Systems

$7.70

-0.34 (-4.23%)

, WFC

Wells Fargo

$53.50

0.23 (0.43%)

05:29
11/15/19
11/15
05:29
11/15/19
05:29
Downgrade
Mitek Systems, Wells Fargo rating change  »

Mitek Systems downgraded…

MITK

Mitek Systems

$7.70

-0.34 (-4.23%)

WFC

Wells Fargo

$53.50

0.23 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

FCX

Freeport McMoRan

$10.81

-0.02 (-0.18%)

, SCCO

Southern Copper

$37.10

-0.27 (-0.72%)

05:25
11/15/19
11/15
05:25
11/15/19
05:25
Recommendations
Freeport McMoRan, Southern Copper analyst commentary  »

Citi makes Freeport…

FCX

Freeport McMoRan

$10.81

-0.02 (-0.18%)

SCCO

Southern Copper

$37.10

-0.27 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$78.54

0.35 (0.45%)

05:24
11/15/19
11/15
05:24
11/15/19
05:24
Initiation
Wabtec initiated  »

Wabtec initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNP

CenterPoint Energy

$26.68

-1.42 (-5.05%)

05:21
11/15/19
11/15
05:21
11/15/19
05:21
Downgrade
CenterPoint Energy rating change  »

CenterPoint Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRK

GeoPark

$18.92

-0.02 (-0.11%)

05:20
11/15/19
11/15
05:20
11/15/19
05:20
Hot Stocks
GeoPark announces all-cash acquisition of Amerisur Resources »

GeoPark announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MITK

Mitek Systems

$7.70

-0.34 (-4.23%)

05:18
11/15/19
11/15
05:18
11/15/19
05:18
Downgrade
Mitek Systems rating change  »

Mitek Systems downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATLKY

Atlas Copco

$0.00

(0.00%)

05:18
11/15/19
11/15
05:18
11/15/19
05:18
Downgrade
Atlas Copco rating change  »

Atlas Copco downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SALRF

Salmar

$0.00

(0.00%)

05:16
11/15/19
11/15
05:16
11/15/19
05:16
Upgrade
Salmar rating change  »

Salmar upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNP

CenterPoint Energy

$26.68

-1.42 (-5.05%)

05:14
11/15/19
11/15
05:14
11/15/19
05:14
Downgrade
CenterPoint Energy rating change  »

CenterPoint Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$0.00

(0.00%)

05:13
11/15/19
11/15
05:13
11/15/19
05:13
Downgrade
Daimler AG rating change  »

Daimler AG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWAV

ShockWave Medical

$36.47

1.38 (3.93%)

05:11
11/15/19
11/15
05:11
11/15/19
05:11
Syndicate
ShockWave Medical 2.482M share Secondary priced at $36.25 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

05:10
11/15/19
11/15
05:10
11/15/19
05:10
General news
FX Action: The yen is trading softer »

FX Action: The yen is…

BGNE

BeiGene

$195.90

-1.25 (-0.63%)

05:09
11/15/19
11/15
05:09
11/15/19
05:09
Recommendations
BeiGene analyst commentary  »

BeiGene price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 27

    Feb

NXTC

NextCure

$38.60

0.85 (2.25%)

05:09
11/15/19
11/15
05:09
11/15/19
05:09
Syndicate
NextCure 4.08M share Secondary priced at $36.75 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

AAPL

Apple

$262.66

-1.86 (-0.70%)

05:05
11/15/19
11/15
05:05
11/15/19
05:05
Recommendations
Apple price target raised to $290 from $270 at Piper Jaffray »

Piper Jaffray analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.